Cartan Capital

We are excited to share this month's newsletter - focused on NIL!

We are thrilled to officially share the news: our MuscleView™ technology has received FDA 510(k) Clearance. MuscleView™ uses AI to analyze MSK structures across a wide range of patient demographics, MRI parameters, and manufacturer systems to provide a 3D digital twin. Read today's news release: https://lnkd.in/gA8vyuDb "Achieving FDA 510(k) clearance is a significant milestone for our company and a true testament to the integrity, diligence and collaboration our entire team has brought to Springbok every day over the last several years. This clearance is a key pillar to our commercialization strategy, allowing us to further integrate MuscleView and our cutting-edge muscle analytics into sports medicine, orthopedics, and therapeutic applications." Scott Magargee, CEO and Co-Founder of Springbok Analytics

Couldn’t be more excited to share that I’ll be joining the team at Cartan Capital as Head of Platform. Sports and Health are passion areas for me and I can’t wait to help support innovators as they look to disrupt these industries. Thank you to CiCi Bellis for this incredible opportunity! Let’s go!!

💫We absolutely loved having CiCi Bellis on Episode 20 of the Champion This Podcast. 🎾Cici is a former professional tennis player, having competed in her first US Open at the age of 15 and would eventually go on the win many tournaments throughout her career. In her “next play”, she has now launched her own Venture Capital firm called Cartan Capital which focuses on the sports and health tech industries. 📈 Her episode is linked below in the comments #venturecaptial #podcast #linkedinsports #tennis #sportsinvesting

We are excited to share Issue No. 12 of our newsletter - Living Longer!

We have important news to announce today! Tiny Health has appointed Dr Elisa Song as our Chief Medical Officer and Dr Taylor Sittler as our Board Director. When I first met Elisa Song, MD, it was like a meeting of souls, minds and a singular vision. Dr Song has been educating both parents and practitioners alike about the importance of pediatric gut health for decades and we just got started at Tiny Health. Together, we collaborated and created a professional-version of what we think is the best gut health test in the market: the PRO. When 1 in 2 kids are impacted by at least 1 chronic condition, we believe that there's no great mission than to tackle the root cause of these conditions by modulating the gut microbiome in early life. In the near future, we will be working towards our mutual vision of making pediatric gut health testing the standard of care for all infants, babies and kids. When I first met Taylor Sittler (shoutout to Julia Lipton), I think we spent 2 straight hours speaking about the parallels and learnings from his time at Color and how we may apply them to our clinical growth at Tiny Health. Taylor quickly became a true believer and an angel investor, right before our Series A. A few months later, he even became an avid customer when his son was born. Taylor has been a core part of our R&D and clinical team, and he brings both physician and founder/operator experience to support me on the board, alongside our incredible VC partners Sara Eshelman and Laura González-Estéfani. I am so grateful to have the support of two esteemed physicians and leaders in their field. Our meaningful work together has just begun! This week, for the 2nd year in a row, we'll be speaking at the A4M pediatric symposium in LA, which is chaired by Dr Elisa Song. Our Medical Director Taylor Soderborg, MD, PhD will present our research and knowledge on gut-immune development in the first 1,000 days and strategies to restore missing Bifidobacterium in our children. We have a lot more exciting news in store in the coming quarters - we hope that you'll follow along our journey and support us in changing the statistics in our chronic condition crisis, for both children and adults alike.

Huge thanks to Howie & the New York Post!

We are excited to share the latest edition of our newsletter - focused on startup sports leagues!

From pro tennis to sports VC... w/ guest CiCi Bellis, Founding Partner of Cartan Capital. Cartan Capital is a venture capital firm focused on the sports and health technology markets – particularly Seed and Series A stage companies. 𝐘𝐨𝐮’𝐥𝐥 𝐞𝐧𝐣𝐨𝐲 𝐭𝐡𝐢𝐬 𝐞𝐩𝐢𝐬𝐨𝐝𝐞 𝐚𝐬 𝐰𝐞 𝐝𝐢𝐬𝐜𝐮s𝐬: 🎙 1️⃣ What excited her about VC 2️⃣ Opportunities in racquet sports 3️⃣ Investment areas to keep an eye on Check out the full episode here: https://lnkd.in/ekkjMqUy Insightful segment on tennis and the investment landscape 👇